Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
279.41
-1.61 (-0.57%)
Apr 19, 2024, 3:59 PM EDT - Market closed
Bio-Rad Laboratories Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for BIO stock have an average target of 421.67, with a low estimate of 365 and a high estimate of 480. The average target predicts an increase of 50.91% from the current stock price of 279.41.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BIO stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $400 → $365 | Strong Buy → Hold | Downgrades | $400 → $365 | +30.63% | Apr 3, 2024 |
| UBS | UBS | Strong Buy Maintains $395 → $420 | Strong Buy | Maintains | $395 → $420 | +50.32% | Feb 16, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $484 → $480 | Buy | Maintains | $484 → $480 | +71.79% | Feb 16, 2024 |
| UBS | UBS | Strong Buy Initiates $395 | Strong Buy | Initiates | $395 | +41.37% | Dec 7, 2023 |
| Wells Fargo | Wells Fargo | Buy Maintains $550 → $525 | Buy | Maintains | $550 → $525 | +87.90% | Aug 7, 2023 |
Financial Forecast
Revenue This Year
2.72B
from 2.67B
Increased by 1.86%
Revenue Next Year
2.87B
from 2.72B
Increased by 5.33%
EPS This Year
10.80
from -21.82
EPS Next Year
12.28
from 10.80
Increased by 13.62%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.9B | 3.0B | 3.1B |
| Avg | 2.7B | 2.9B | 3.0B |
| Low | 2.6B | 2.7B | 2.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.7% | 10.3% | 9.3% |
| Avg | 1.9% | 5.3% | 4.2% |
| Low | -1.8% | 1.0% | 0.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 11.88 | 13.28 | 14.87 |
| Avg | 10.80 | 12.28 | 14.15 |
| Low | 10.05 | 11.22 | 13.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 22.9% | 21.1% |
| Avg | - | 13.6% | 15.2% |
| Low | - | 3.9% | 10.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.